Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship

This retrospective analysis involves 569 patients with invasive cancer of the uterine cervix treated with irradiation alone between 1969 and 1980. Treatment consisted of external and intracavitary irradiation and treatment policy remained consistant throughout the study interval. In early stage dise...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 1989-11, Vol.17 (5), p.973-978
Hauptverfasser: Kim, Robert Y., Trotti, Andy, Wu, Ching-Jung, Soong, S.J., Salter, Merle M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 978
container_issue 5
container_start_page 973
container_title International journal of radiation oncology, biology, physics
container_volume 17
creator Kim, Robert Y.
Trotti, Andy
Wu, Ching-Jung
Soong, S.J.
Salter, Merle M.
description This retrospective analysis involves 569 patients with invasive cancer of the uterine cervix treated with irradiation alone between 1969 and 1980. Treatment consisted of external and intracavitary irradiation and treatment policy remained consistant throughout the study interval. In early stage disease (FIGO IA, III, and IIA), pelvic failure was 4.6%, 11.2%, and 8.2%, respectively. In late stage disease (FIGO IIB, III, and IVA), pelvic failure was 30.1%, 52.3%, and 69.2%, respectively. Further analysis revealed that total dose at point A is well correlated with pelvic control. An aggressive treatment is crucial in late stage disease in determining the probability of pelvic tumor control and survival. Methods of dose prescription, dose-response relationships, treatment philosophy and its therapeutic implications are discussed.
doi_str_mv 10.1016/0360-3016(89)90144-2
format Article
fullrecord <record><control><sourceid>elsevier_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_5100381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0360301689901442</els_id><sourcerecordid>0360301689901442</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-23571e700930e4d828f2f5fd66903889226d370445d82ab94e9f68015bae3c233</originalsourceid><addsrcrecordid>eNp9kF1rFDEUhoNY6lr9BwpBEPRi9GSSmUl6IZSirVAQRMG7kE1O2MhsZkiyi8U_b2Z3qXe9yiHvxzk8hLxi8IEB6z8C76HhdXon1XsFTIimfUJWTA6q4V336ylZPViekec5_wYAxgZxTs5bCRI6tSJ_vxsXTAlTpGacItIQadkgLQlN2WIsdPLUmmgxLdMi7QqmUJ31ax_-XNKraMb7HPKizzjug6XehHGXkJroqJsy0oR5nuJhGA_b8ibML8iZN2PGl6f3gvz88vnH9W1z9-3m6_XVXWOFhNK0vBsYDgCKAwonW-lb33nX9wq4lKpte8cHEKKrmlkrgcr3Eli3Nshty_kFeXPsnXIJOttQ0G7sFCPaojsGtYVVkziabJpyTuj1nMLWpHvNQC-89QJTLzC1VPrAW7c19voYm3frLbqH0Alw1d-edJOtGX2qKEP-3636HgT01ffp6MMKYh8wLXdixe5CWs50U3j8kH9KsZvj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kim, Robert Y. ; Trotti, Andy ; Wu, Ching-Jung ; Soong, S.J. ; Salter, Merle M.</creator><creatorcontrib>Kim, Robert Y. ; Trotti, Andy ; Wu, Ching-Jung ; Soong, S.J. ; Salter, Merle M.</creatorcontrib><description>This retrospective analysis involves 569 patients with invasive cancer of the uterine cervix treated with irradiation alone between 1969 and 1980. Treatment consisted of external and intracavitary irradiation and treatment policy remained consistant throughout the study interval. In early stage disease (FIGO IA, III, and IIA), pelvic failure was 4.6%, 11.2%, and 8.2%, respectively. In late stage disease (FIGO IIB, III, and IVA), pelvic failure was 30.1%, 52.3%, and 69.2%, respectively. Further analysis revealed that total dose at point A is well correlated with pelvic control. An aggressive treatment is crucial in late stage disease in determining the probability of pelvic tumor control and survival. Methods of dose prescription, dose-response relationships, treatment philosophy and its therapeutic implications are discussed.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/0360-3016(89)90144-2</identifier><identifier>PMID: 2808059</identifier><identifier>CODEN: IOBPD3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>550603 - Medicine- External Radiation in Therapy- (1980-) ; Adenocarcinoma - mortality ; Adenocarcinoma - pathology ; Adenocarcinoma - radiotherapy ; Adult ; Aged ; Biological and medical sciences ; BODY ; Carcinoma of the cervix ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - radiotherapy ; DISEASES ; Dose-Response Relationship, Radiation ; DOSE-RESPONSE RELATIONSHIPS ; DOSES ; Female ; Female genital diseases ; FEMALE GENITALS ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; MEDICINE ; Middle Aged ; Neoplasm Staging ; NEOPLASMS ; NUCLEAR MEDICINE ; ORGANS ; PATIENTS ; Pelvic failure ; Pelvic Neoplasms - secondary ; RADIATION DOSES ; Radiation treatment ; RADIOLOGY ; RADIOLOGY AND NUCLEAR MEDICINE ; RADIOTHERAPY ; Retrospective Studies ; SURVIVAL CURVES ; THERAPY ; Tumors ; Uterine Cervical Neoplasms - mortality ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - radiotherapy ; UTERUS</subject><ispartof>International journal of radiation oncology, biology, physics, 1989-11, Vol.17 (5), p.973-978</ispartof><rights>1989</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-23571e700930e4d828f2f5fd66903889226d370445d82ab94e9f68015bae3c233</citedby><cites>FETCH-LOGICAL-c480t-23571e700930e4d828f2f5fd66903889226d370445d82ab94e9f68015bae3c233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0360-3016(89)90144-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19660406$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2808059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/5100381$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Robert Y.</creatorcontrib><creatorcontrib>Trotti, Andy</creatorcontrib><creatorcontrib>Wu, Ching-Jung</creatorcontrib><creatorcontrib>Soong, S.J.</creatorcontrib><creatorcontrib>Salter, Merle M.</creatorcontrib><title>Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship</title><title>International journal of radiation oncology, biology, physics</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>This retrospective analysis involves 569 patients with invasive cancer of the uterine cervix treated with irradiation alone between 1969 and 1980. Treatment consisted of external and intracavitary irradiation and treatment policy remained consistant throughout the study interval. In early stage disease (FIGO IA, III, and IIA), pelvic failure was 4.6%, 11.2%, and 8.2%, respectively. In late stage disease (FIGO IIB, III, and IVA), pelvic failure was 30.1%, 52.3%, and 69.2%, respectively. Further analysis revealed that total dose at point A is well correlated with pelvic control. An aggressive treatment is crucial in late stage disease in determining the probability of pelvic tumor control and survival. Methods of dose prescription, dose-response relationships, treatment philosophy and its therapeutic implications are discussed.</description><subject>550603 - Medicine- External Radiation in Therapy- (1980-)</subject><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma - radiotherapy</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>BODY</subject><subject>Carcinoma of the cervix</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>DISEASES</subject><subject>Dose-Response Relationship, Radiation</subject><subject>DOSE-RESPONSE RELATIONSHIPS</subject><subject>DOSES</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>FEMALE GENITALS</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>MEDICINE</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>NEOPLASMS</subject><subject>NUCLEAR MEDICINE</subject><subject>ORGANS</subject><subject>PATIENTS</subject><subject>Pelvic failure</subject><subject>Pelvic Neoplasms - secondary</subject><subject>RADIATION DOSES</subject><subject>Radiation treatment</subject><subject>RADIOLOGY</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>RADIOTHERAPY</subject><subject>Retrospective Studies</subject><subject>SURVIVAL CURVES</subject><subject>THERAPY</subject><subject>Tumors</subject><subject>Uterine Cervical Neoplasms - mortality</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - radiotherapy</subject><subject>UTERUS</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kF1rFDEUhoNY6lr9BwpBEPRi9GSSmUl6IZSirVAQRMG7kE1O2MhsZkiyi8U_b2Z3qXe9yiHvxzk8hLxi8IEB6z8C76HhdXon1XsFTIimfUJWTA6q4V336ylZPViekec5_wYAxgZxTs5bCRI6tSJ_vxsXTAlTpGacItIQadkgLQlN2WIsdPLUmmgxLdMi7QqmUJ31ax_-XNKraMb7HPKizzjug6XehHGXkJroqJsy0oR5nuJhGA_b8ibML8iZN2PGl6f3gvz88vnH9W1z9-3m6_XVXWOFhNK0vBsYDgCKAwonW-lb33nX9wq4lKpte8cHEKKrmlkrgcr3Eli3Nshty_kFeXPsnXIJOttQ0G7sFCPaojsGtYVVkziabJpyTuj1nMLWpHvNQC-89QJTLzC1VPrAW7c19voYm3frLbqH0Alw1d-edJOtGX2qKEP-3636HgT01ffp6MMKYh8wLXdixe5CWs50U3j8kH9KsZvj</recordid><startdate>19891101</startdate><enddate>19891101</enddate><creator>Kim, Robert Y.</creator><creator>Trotti, Andy</creator><creator>Wu, Ching-Jung</creator><creator>Soong, S.J.</creator><creator>Salter, Merle M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>OTOTI</scope></search><sort><creationdate>19891101</creationdate><title>Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship</title><author>Kim, Robert Y. ; Trotti, Andy ; Wu, Ching-Jung ; Soong, S.J. ; Salter, Merle M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-23571e700930e4d828f2f5fd66903889226d370445d82ab94e9f68015bae3c233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>550603 - Medicine- External Radiation in Therapy- (1980-)</topic><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma - radiotherapy</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>BODY</topic><topic>Carcinoma of the cervix</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>DISEASES</topic><topic>Dose-Response Relationship, Radiation</topic><topic>DOSE-RESPONSE RELATIONSHIPS</topic><topic>DOSES</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>FEMALE GENITALS</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>MEDICINE</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>NEOPLASMS</topic><topic>NUCLEAR MEDICINE</topic><topic>ORGANS</topic><topic>PATIENTS</topic><topic>Pelvic failure</topic><topic>Pelvic Neoplasms - secondary</topic><topic>RADIATION DOSES</topic><topic>Radiation treatment</topic><topic>RADIOLOGY</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>RADIOTHERAPY</topic><topic>Retrospective Studies</topic><topic>SURVIVAL CURVES</topic><topic>THERAPY</topic><topic>Tumors</topic><topic>Uterine Cervical Neoplasms - mortality</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - radiotherapy</topic><topic>UTERUS</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Robert Y.</creatorcontrib><creatorcontrib>Trotti, Andy</creatorcontrib><creatorcontrib>Wu, Ching-Jung</creatorcontrib><creatorcontrib>Soong, S.J.</creatorcontrib><creatorcontrib>Salter, Merle M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>OSTI.GOV</collection><jtitle>International journal of radiation oncology, biology, physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Robert Y.</au><au>Trotti, Andy</au><au>Wu, Ching-Jung</au><au>Soong, S.J.</au><au>Salter, Merle M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship</atitle><jtitle>International journal of radiation oncology, biology, physics</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>1989-11-01</date><risdate>1989</risdate><volume>17</volume><issue>5</issue><spage>973</spage><epage>978</epage><pages>973-978</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><coden>IOBPD3</coden><abstract>This retrospective analysis involves 569 patients with invasive cancer of the uterine cervix treated with irradiation alone between 1969 and 1980. Treatment consisted of external and intracavitary irradiation and treatment policy remained consistant throughout the study interval. In early stage disease (FIGO IA, III, and IIA), pelvic failure was 4.6%, 11.2%, and 8.2%, respectively. In late stage disease (FIGO IIB, III, and IVA), pelvic failure was 30.1%, 52.3%, and 69.2%, respectively. Further analysis revealed that total dose at point A is well correlated with pelvic control. An aggressive treatment is crucial in late stage disease in determining the probability of pelvic tumor control and survival. Methods of dose prescription, dose-response relationships, treatment philosophy and its therapeutic implications are discussed.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>2808059</pmid><doi>10.1016/0360-3016(89)90144-2</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-3016
ispartof International journal of radiation oncology, biology, physics, 1989-11, Vol.17 (5), p.973-978
issn 0360-3016
1879-355X
language eng
recordid cdi_osti_scitechconnect_5100381
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 550603 - Medicine- External Radiation in Therapy- (1980-)
Adenocarcinoma - mortality
Adenocarcinoma - pathology
Adenocarcinoma - radiotherapy
Adult
Aged
Biological and medical sciences
BODY
Carcinoma of the cervix
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - radiotherapy
DISEASES
Dose-Response Relationship, Radiation
DOSE-RESPONSE RELATIONSHIPS
DOSES
Female
Female genital diseases
FEMALE GENITALS
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
MEDICINE
Middle Aged
Neoplasm Staging
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PATIENTS
Pelvic failure
Pelvic Neoplasms - secondary
RADIATION DOSES
Radiation treatment
RADIOLOGY
RADIOLOGY AND NUCLEAR MEDICINE
RADIOTHERAPY
Retrospective Studies
SURVIVAL CURVES
THERAPY
Tumors
Uterine Cervical Neoplasms - mortality
Uterine Cervical Neoplasms - pathology
Uterine Cervical Neoplasms - radiotherapy
UTERUS
title Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiation%20alone%20in%20the%20treatment%20of%20cancer%20of%20the%20uterine%20cervix:%20Analysis%20of%20pelvic%20failure%20and%20dose%20response%20relationship&rft.jtitle=International%20journal%20of%20radiation%20oncology,%20biology,%20physics&rft.au=Kim,%20Robert%20Y.&rft.date=1989-11-01&rft.volume=17&rft.issue=5&rft.spage=973&rft.epage=978&rft.pages=973-978&rft.issn=0360-3016&rft.eissn=1879-355X&rft.coden=IOBPD3&rft_id=info:doi/10.1016/0360-3016(89)90144-2&rft_dat=%3Celsevier_osti_%3E0360301689901442%3C/elsevier_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2808059&rft_els_id=0360301689901442&rfr_iscdi=true